I. G. Schouten

Registries: roles, objectives and registry data study outcomes

J. Fuge, J. Stolk, S. Janciauskiene, 2019, α1-Antitrypsin Deficiency.

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches

P. Iadarola, S. Viglio, J. Stolk, 2021, International journal of molecular sciences.

The Course of AαVal541 as a Proteinase 3 Specific Neo-Epitope after Alpha-1-Antitrypsin Augmentation in Severe Deficient Patients

P. Hiemstra, J. Stolk, D. Moes, 2021, International journal of molecular sciences.

Long-term effect of α1-antitrypsin augmentation therapy on the decline of FEV1 in deficient patients: an analysis of the AIR database

R. Tsonaka, R. Stockley, M. Miravitlles, 2021, ERJ Open Research.

Effect of intravenous alpha-1-antitrypsin augmentation therapy on proteinase-3-generated AaVal541 in deficient patients

P. Hiemstra, J. Stolk, R. Mumford, 2021, Airway pharmacology and treatment.